TNGX
Tango Therapeutics, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth -10.0% ·
share flow +20.9% ·
net new positions -11.1%
· formula
Concentrated accumulation: rising shares among fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 595.91K | $14.87M | n/a | n/a |
| Q2 2026 | 96 | +22 | 90.51M | $2.83B | +24 | −2 |
| Q1 2026 | 77 | 0 | 72.21M | $1.51B | +9 | −9 |
| Q4 2025 | 76 | 0 | 64.83M | $574.42M | +1 | −1 |
| Q3 2025 | 19 | +2 | 27.21M | $228.58M | +3 | −1 |
| Q2 2025 | 14 | 0 | 22.55M | $115.47M | +1 | −1 |
| Q1 2025 | 11 | +1 | 6.63M | $9.09M | +2 | −1 |
| Q4 2024 | 10 | 0 | 4.99M | $15.42M | +3 | −3 |
| Q3 2024 | 9 | -1 | 6.83M | $52.57M | +1 | −2 |
| Q2 2024 | 10 | n/a | 5.64M | $48.44M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Citadel Advisors ✦ | 2.69M | +118.7% | $20.74M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Adage Capital Partners ✦ | 2.29M | 0.0% | $17.67M | 0.0% | Held | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 1.37M | +11.6% | $10.54M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 4 | Fisher Asset Management ✦ | 154.95K | 0.0% | $1.19M | 0.0% | Held | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 143.21K | -4.4% | $1.10M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 6 | Marshall Wace ✦ | 73.12K | New | $563,040 | 0.0% | New | 1 | SEC ↗ |
| 7 | Two Sigma Investments ✦ | 68.16K | -24.9% | $524,847 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 16.18K | +6.2% | $125,000 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 14.21K | -31.2% | $109,386 | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Marshall Wace | $563,040 | 0.0% |
Exited
| Point72 Asset Management | $3.84M | was 0.0% |
| Millennium Management | $127,936 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 193 holders, 180.17M shares, $3.72B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 600 sh · $15,192
Officer · 26.40K sh · $645,604
Officer · 2.40K sh · $60,412
Officer · 700 sh · $15,962
Officer · 5.10K sh · $122,238
Officer · 27.00K sh · $603,909
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology